GCM
FLNA

Graham Capital Management’s Filana Therapeutics FLNA Stock Holding History

Graham Capital Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$42.8K Sell
25,312
-103,391
-80% -$213K ﹤0.01% 1098
2025
Q4 		$255K Buy
128,703
+10,776
+9% +$34.5K 0.01% 935
2025
Q3 		$343K Buy
+117,927
New +$271K 0.01% 795

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Graham Capital Management's FLNA Position: Q1 2026 in Review

Graham Capital Management reduced its Filana Therapeutics (FLNA) stake by 80% in Q1 2026, selling an estimated $213K and leaving 25,312 shares worth $42.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Graham Capital Management first reported a position in FLNA in Q3 2025 and has held it in 3 quarters since. The position peaked at $343K in Q3 2025. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Graham Capital Management held 25,312 shares of Filana Therapeutics worth $42.8K as of Q1 2026.
  • Graham Capital Management sold 103,391 Filana Therapeutics shares in Q1 2026, an estimated $213K.
  • Filana Therapeutics made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #1098 holding.
  • Graham Capital Management first reported a position in Filana Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • Graham Capital Management's Filana Therapeutics position peaked at $343K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.